glp 1 generations Revolutionizing obesity treatment: The emerging role of GLP-1 receptor agonists and next-generation pharmacotherapies Glucagon-Like Peptide-1: New Regulator in

Anifrolumab, a mAb that binds to IFNAR and inhibits the activity of all type-I IFNs by blocking their binding, is the sole anti-IFN therapy that have undergone Phase III randomized controlled trials (RCTs) (131)

Xiao X, Song B-L

It remains controversial whether melanosiscoli is associated with an increased risk for colorectal cancer

Understanding L-Carnitine Injections L-carnitine is a naturally occurring amino acid derivative that plays a critical role in energy production

Of note, only small number of sudies investigated this outcome with heterogenity in inclusion criteria among study populations, and differences in AOX combinations and SDF assays used